‘Clorox Recalls Pine-Sol Scented Multi-Surface Cleaners, CloroxPro Pine-Sol All Purpose Cleaners, And Clorox Professional Pine-Sol Lemon Fresh Cleaners Due To Risk Of Exposure To Bacteria’
Clorox Recalls Pine-SolTM Scented Multi-Surface Cleaners, CloroxProTM Pine-SolTM All Purpose Cleaners, and Clorox® ProfessionalTM Pine-SolTM Lemon F
Cronos Group Confirms Earlier SEC Report On Settlement Agreement; Co. Agreed To Pay Total Of C$1.34M To Fully Settle Matter, Acknowledged That It Had Not Complied With Certain Requirements
Cronos Group Inc. (NASDAQ:CRON) (TSX:CRON) ("Cronos" or the "Company") today announced that it has reached final settlement agreements with each of the U.S. Securities and Exchange Commission (the
US Charges More Than A Dozen Chinese Agents With Multiple Acts Of Espionage: What You Need To Know
U.S. Attorney General Merrick Garland accused China of committing acts of espionage against the United States in a Monday press conference. Here's what you need to know:
Lithium Americas Reports Two Contractor Fatalities At Caucharí-Olaroz Lithium Project In Jujuy, Argentina On October 23
Lithium Americas Corp. (TSX:LAC) (NYSE:LAC) ("Lithium Americas" or the "Company") is deeply saddened to report two fatalities at its Caucharí-Olaroz lithium project
Telecommunications Company Involved In U.S. Obstruction Case Is Huawei
- Reuters Citing Person Familiar With Situation
Artesian Water Company Announces Credit To Delaware Customers With Proceeds From Settlement Agreement
Artesian Resources Corporation (NASDAQ:ARTNA), a leading provider of water and wastewater services, and related services, on the Delmarva Peninsula, today announced that its principal operating subsidiary, Artesian Water
Credit Suisse Group Reaches Settlement in French Legacy Case; Fine Comprising a Profit Disgorgement of €65.6M, Payment of Additional €57.4Ml; €115M to French State
Credit Suisse announces today that it has reached a settlement with the Parquet National Financier (PNF) to resolve a legacy matter in relation to an investigation into historical cross-border private-banking services. The settlement provides for a public interest fine comprising a profit disgorgement of EUR 65.6 million and the payment of an additional amount of EUR 57.4 million.
NeuroBo Pharmaceuticals Files For Patent Application Titled ‘GEMCABENE, PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF, COMPOSITIONS THEREOF AND METHODS OF USE THEREFOR (FOR THE TREATMENT OF VARIOUS CONDITIONS INCLUDING DYSLIPIDEMIA)’
https://ppubs.uspto.gov/dirsearch-public/image-conversion/convert?url=us-pgpub/US/2022/0332/672/00000001.tif
Vanda Pharmaceuticals Announces Orphan Drug Designation Granted For VPO-227, A Novel Candidate For The Treatment Of Cholera
Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation for VPO-227 for the treatment of cholera.